Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000627256 | SCV000748248 | pathogenic | not provided | 2022-01-04 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 21258341) |
Labcorp Genetics |
RCV001857364 | SCV002231494 | pathogenic | Jeune thoracic dystrophy; Nephronophthisis | 2024-10-30 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg411*) in the TTC21B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TTC21B are known to be pathogenic (PMID: 18327258, 21068128, 21258341, 23559409, 24876116, 25492405, 27491411, 29068549). This variant is present in population databases (rs185089786, gnomAD 0.009%). This premature translational stop signal has been observed in individual(s) with Jeune asphyxiating thoracic dystrophy (PMID: 21258341). ClinVar contains an entry for this variant (Variation ID: 30938). For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000023927 | SCV000045218 | pathogenic | Asphyxiating thoracic dystrophy 4 | 2011-03-01 | no assertion criteria provided | literature only |